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Abstract
Introduction: Evaluation of thyroid function is often requested and therefore defining paediatric reference intervals (RIs) is of vital importance. Cu-
rrently, there is a distinct lack of paediatric RIs for thyroid function tests in Croatia. Thus, we established RIs for thyroid stimulating hormone (TSH), 
total triiodothyronine (TT3), total thyroxine (TT4), free triiodothyronine (FT3) and free thyroxine (FT4) in the Croatian paediatric population.
Materials and methods: Reference intervals were calculated from 397 apparently healthy children, aged from 2 days to < 19 years. Serum sam-
ples were analysed for thyroid function tests on the Abbott Architect i2000. Age- and sex-specific 95% RIs with 90% confidence intervals were esta-
blished according to Clinical and Laboratory Standards Institute guidelines. To express the magnitude of sex and age variation, standard deviation 
ratio (SDR) was calculated using two-level nested ANOVA. The criterion for considering partitioning reference values was set to SDR > 0.3.
Results: All thyroid function tests required age partitioning, confirmed by SDR above 0.3. There was no need for sex partitioning, confirmed by SDR 
below 0.3. Still, FT3 was partitioned due to visually noticeable sex related difference for the oldest group (12 years to < 19 years).
Conclusion: This is the first study to establish RIs for thyroid function tests in the Croatian paediatric population. We propose RIs for widely used 
Abbott platform, thus giving laboratories method- and population-specific paediatric RIs for thyroid function tests that should improve clinical test 
interpretation. 
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Introduction 
Reference interval (RI) is commonly defined as 
range of values within two reference limits, includ-
ing the limits themselves (1). It represents an im-
portant tool, which aids clinicians in diagnosing, 
making therapeutic decisions, monitoring, and 
generally in differentiation between healthy and 
non-healthy individuals. Establishing paediatric 
specific RIs, despite being a difficult and sensitive 
task, became an essential demand for appropriate 
patient management (2).
The assessment of thyroid function is the most fre-
quently applied endocrine investigation in chil-
dren and adolescents. An important aspect of thy-
roid function is the dynamic change that takes 
place during growth and development (3). Al-
though interpretation of thyroid function tests is 
similar to that applied in adults, the RIs differ since 
they depend on the maturation of the hypotha-
lamic-pituitary-thyroid axis. Adult RIs are often the 
only available ones when interpreting laboratory 
results for paediatric population. Relying solely on 
adult RIs could however lead to unnecessary diag-
nostic procedures and erroneous therapeutic de-
cisions. Hence, it is essential to use appropriate 
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age-related RIs and to interpret results based on a 
thorough knowledge of thyroid physiology from 
neonatal age to adulthood (4).
In the last decade, there were multiple published 
studies with RIs for thyroid hormones in children 
and adolescents (5). Differences in study design 
and method of measurement create difficulties 
when comparing these results. Furthermore, it is 
well known that the Abbott Architect method pro-
duces lower TSH results, which leads to lower TSH 
values in studies using this method (6-9). Even in 
studies using the same method, the differences 
are still present due to variability in subject recruit-
ment (hospital patients vs healthy children), age- 
and sex- partitioning, ethnicity and iodine status 
of studied population (10-14). 
Croatian laboratories are responsible for providing 
appropriate RIs for local population. Usually, they 
rely on literature data derived from other popula-
tions and verify them according to Clinical and 
Laboratory Standards Institute (CLSI) protocol be-
fore implementation (1,15). The concentration of 
thyroid hormones can be influenced by multiple 
factors other than age and sex, such as ethnicity, 
iodine status and body mass index (16-18). Cur-
rently, there is a distinct lack of paediatric RIs for 
thyroid function tests in Croatia.
We intended to establish RIs for thyroid function 
tests including thyroid stimulating hormone (TSH), 
total triiodothyronine (TT3), total thyroxine (TT4), 
free triiodothyronine (FT3) and free thyroxine (FT4) 
in the Croatian paediatric population. The meth-
od-specific RIs empirically determined in this study 
are expected to improve the quality of the immu-
noassay interpretation for paediatric care in many 
hospitals and clinical laboratories using the Ab-




The study population was prospectively recruited 
from October 2018 to July 2020 in the University 
Hospital Center Sestre milosrdnice, Zagreb, Croa-
tia. The study was approved by hospital’s Ethics 
Review Board. In total, 444 apparently healthy chil-
dren, 207 males and 237 females, younger than 19 
years of age entered the study. Residual serum 
samples were collected from routinely ordered 
laboratory requests from paediatric outpatients 
and maternity ward. Subjects were recruited by 
two experienced paediatricians according to inclu-
sion and exclusion criteria. Inclusion criteria were 
defined as: age < 19 years, personal medical histo-
ry and clinical examination non-suggestive of thy-
roid disease. Subject were excluded if any of the 
following criteria have been met: premature birth 
(for neonates), established chronic disease, acute 
illness within 7 days of collection, intake of medi-
cations known to affect serum concentration of 
thyroid hormones, body mass index below 5 or 
above 95 percentiles for age and sex. Samples 
with thyroid peroxidase antibody (TPO-Ab) and 
thyroglobulin antibody (TG-Ab) results above 
manufacturer’s declared cut-off value of 5.6 kU/L 
and 4.1 kU/L, respectively, were excluded except 
for neonatal samples. Ideally, study should ex-
clude samples with positive TPO-Ab and TG-Ab re-
sults, but this would significantly affect number of 
neonatal samples. Although diffusion of TPO-Ab 
through placental barrier is possible, the presence 
of TPO-Ab and TG-Ab in children does not affect 
estimation of RIs of thyroid function tests (19,20). 
All subjects fulfilling conditions of inclusion and 
exclusion criteria were defined as apparently 
healthy.
Methods
Neonatal blood samples were collected regardless 
of the time in the day or fasting state by heel prick 
in micro tubes (0.5 mL MiniCollect, Greiner Bio-
One GmbH, Kremsmünster, Austria). Other blood 
samples were collected in fasting state from 7.00 
to 10.00 am by venipuncture in test tubes with clot 
activator (2 or 4 mL Vacuette, Greiner Bio-One 
GmbH, Kremsmünster, Austria). After clotting, 
blood samples were centrifuged at 2200 RCF for 
10 minutes.
Fresh serum samples were firstly analysed for TPO-
Ab and TG-Ab. If antibodies tested negative, sam-
https://doi.org/10.11613/BM.2021.030702 Biochem Med (Zagreb) 2021;31(3):030702 
  3
Bokulić A. et al. Paediatric reference intervals for thyroid function tests
ples were further analysed for TSH, TT3, TT4, FT3 
and FT4. Neonatal samples were tested for all hor-
mones irrespective of the antibodies test results. 
Due to limited volume, not all hormones were 
measured in each individual sample. All measure-
ments were performed on the Abbott Architect 
i2000 chemiluminescent microparticle immunoas-
say (Abbott Diagnostics, Abbott Park, USA). Assay 
precision was evaluated according to CLSI EP15-A2 
guidelines using two levels of quality controls 
measured in triplicate for five consecutive days 
(Table 1) (21). Prior to analysis, authorized person-
nel verified calibrations and quality controls. 
Statistical analysis
Data collection and analysis were performed ac-
cording to CLSI EP28-A3c guidelines (1). Hormone 
concentrations were plotted against age and sex. 
Plotted data were visually inspected for possible 
age and sex stratification and aberrant results. 
Shapiro-Wilk test was applied for testing normali-
ty. Outliers were tested using Tukey’s method and 
subsequently eliminated. Based on sample num-
bers (< 120 vs ≥ 120) and data distribution (normal 
vs non-Gaussian) in each subgroup, 95% RIs with 
90% confidence intervals were calculated with ap-
propriate statistical method as follows: (i) para-
metric - ≥ 120 samples with normal distribution; (ii) 
nonparametric percentile - ≥ 120 samples with 
non-Gaussian distribution; (iii) robust - < 120 sam-
ples with normal distribution or after Box-Cox 
transformation for non-Gaussian distribution. 
Method proposed by Ichihara and Boyd was used 
to evaluate the need for partitioning (22,23). The 
advantage of the nested ANOVA is to evaluate the 
magnitude of variation between three or more 
categories. Thus, we used the standard deviation 
ratio (SDR) for quantification of sex and age-relat-
ed differences. In summary, two-level nested ANO-
VA was performed to calculate standard devia-
tions (SD) of reference values for age (SDAge), sex 
(SDSex) and SD attributable to net-between-indi-
vidual variation (SDBI). Nested ANOVA computa-
tion was done after logarithmic transformation of 
reference values. To express the magnitude of 
each source of variation, SDR was calculated by di-
viding SDAge and SDSex with SDBI. Criterion for con-
sidering partitioning reference values was set to 
SDR > 0.3. Results were provided through statisti-
cal software MedCalc version 19.2.1 (MedCalc Soft-
ware Ltd, Ostend, Belgium) and Minitab version 
19.2 (Minitab Statistical Software, AppOnFly Inc., 
San Francisco, USA).
Results 
From a total of 444 subjects, 33 samples were ex-
cluded due to positive TPO-Ab and/or TG-Ab re-
sults. From 88 neonatal samples, 21 were TPO-Ab 
and/or TG-Ab positive, but were included in the 
study. After testing for outliers with Tukey method, 
397 reference individuals, 187 boys and 210 girls, 
were selected for establishing RIs. Age- and sex-
specific 95% RIs, 90% confidence intervals of the 
lower and upper reference limit and SDRs are pre-





Analyte (unit) Mean Within run Within laboratory Mean Within run Within laboratory
TSH (mIU/L) 0.017 3.9 4.5 3.48 1.4 1.8
TT3 (nmol/L) 1.1 2.7 3.0 2.6 3.5 4.0
TT4 (nmol/L) 68 2.5 2.9 138 3.1 3.0
FT3 (pmol/L) 2.7 4.5 5.2 8.5 2.4 3.5
FT4 (pmol/L) 10.9 2.3 2.4 28.7 2.8 2.5
TSH - thyroid stimulating hormone. TT3 - total triiodothyronine. TT4 - total thyroxine. FT3 - free triiodothyronine. FT4 - free 
thyroxine. CV - coefficient of variation.
Table 1. Assay precision results
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Reference interval Nested ANOVA
Analyte 








90% CI SDRAge SDRSex
TSH 
(mIU/L)
2 days to < 2 months* M+F 102 2.28 0.50 6.54 0.41-0.64 5.71-7.35
0.34 0.002 months to < 14 years‡ M+F 170 1.76 0.80 4.61 0.59-0.83 3.83-4.99
14 years to < 19 years‡ M+F 125 1.51 0.58 3.60 0.42-0.67 3.14 – 3.88
TT3 
(nmol/L)
2 days to < 1 year† M+F 71 2.4 1.0 3.6 0.8-1.3 3.4-3.8
0.64 0.13
1 year to < 6 years† M+F 63 2.3 1.7 2.9 1.6-1.8 2.8-3.1
6 years to < 14 years† M+F 66 2.1 1.4 2.8 1.3-1.5 2.7-2.9
14 years to < 19 years† M+F 117 1.8 1.3 2.3 1.2-1.4 2.2-2.4
TT4 
(nmol/L)
7 days to < 1 year† M+F 55 134 82 188 73-91 176-199
1.03 0.001 year to < 9 years† M+F 97 114 81 147 77-86 141-152
9 years to < 19 years§ M+F 148 97 68 126 64-71 123-130
FT3 
(pmol/L)
2 days to < 1 year† M+F 74 4.8 2.4 7.4 2.0-2.8 7.0-7.8
0.80 0.21
1 year to < 12 years† M+F 113 5.0 3.5 6.6 3.3-3.7 6.3-6.8
12 years to < 19 years† M 45 4.4 3.4 6.0 3.2-3.7 5.7-6.3
12 years to < 19 years† F 85 4.4 3.2 5.5 2.9 - 3.3 5.3 - 5.7
FT4 
(pmol/L)
2 days to < 15 days† M+F 68 19.8 11.8 28.0 10.3 - 13.1 26.4 - 29.6
1.64 0.0015 days to < 1 year* M+F 54 14.2 11.3 18.9 10.8 - 11.8 17.7 - 20.1
1 year to < 19 years§ M+F 241 13.2 10.5 15.9 10.2 - 10.7 15.7 - 16.2
TSH - thyroid stimulating hormone. TT3 - total triiodothyronine. TT4 - total thyroxine. FT3 - free triiodothyronine. FT4 - free thyroxine. 
M – male. F – female. *Robust method (Box-Cox transformation). †Robust method. ‡Nonparametric percentile method. §Parametric 
method. SDRAge and SDRSex were computed by two-level nested ANOVA. SDRSex - standard deviation ratio for between-sex 
variations. SDRAge - standard deviation ratio for between-age variations. CI – confidence interval.
Table 2. Age- and sex-specific reference intervals with standard deviation ratios
of thyroid function tests against age and sex. All 
RIs are defined beginning with 2-day-old new-
borns, except TT4. The concentration of TT4 in the 
first days of life showed grossly scattered data that 
would affect upper reference limit and widen con-
fidence interval. Since TT4 is not usually requested 
in new-borns, we decided to exclude results of 
new-borns younger than 7 days. Significant differ-
ences between age partitions were observed in all 
thyroid function tests with SDRAge above 0.3 con-
firming partitioning data by age is appropriate 
and justifiable. Calculated SDRSex showed there is 
no need for sex stratification for any of the tested 
hormones. Figure 2 shows the interval plot for the 
only two analytes with measurable SDRSex, TT3 
and FT3. Even though SDRSex was less than 0.3, 
FT3 was partitioned due to noticeable sex related 
difference for the oldest group (12 years to < 19 
years). 
Discussion
This study establishes age- and sex-specific RIs for 
thyroid function tests, derived from Croatian pae-
diatric population using Abbott Architect method 
and confirms the necessity of establishing popula-
tion specific RIs.
TSH is the first and the most important laboratory 
test used to evaluate thyroid function. As expect-
ed, surge in the concentration of TSH within first 
two months after birth and wider RIs are compara-
ble to previous studies. With regard to method-
matched group for the new-borns, only two stud-
ies reported RIs on the Abbott platform. The best 
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Figure 1. Age-specific scatter plots for thyroid function tests. Males are shown in black, females in grey. (A) TSH - thyroid stimulating 
hormone; (B) TT3 - total triiodothyronine; (C) TT4 - total thyroxine: (D) FT3 - free triiodothyronine; (E) FT4 - free thyroxine.
agreement is noticed in the upper limit with Sol-
din et al., which defined the same age group as 
our study (< 2 months) (14). Whereas the Canadian 
Laboratory Initiative on Pediatric Reference Inter-
vals (CALIPER) study showed slightly lower upper 
reference limit, probably due to setting upper age 
limit to < 6 months (12). Most of the studies reveal 
significant reduction of TSH in adolescence in pe-
riod between 11 and 15 years of age. The differ-
ences in the age groups could be from inconsist-
ency in applied partitioning criteria (visual and sta-
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Figure 2. Interval plots by age groups. Values are presented as mean and 95% confidence intervals for (A) TT3 - total triiodothyro-
nine and (B) FT3 - free triiodothyronine. 
ed age groups) (10-14,24,25). Visual inspection and 
statistical analysis of our data confirmed TSH parti-
tioning at the age of 14. Regardless of different 
age groups, estimated RIs are similar with meth-
od-matched studies (10-14).
Our results showed TT4 and TT3 concentrations at 
the highest in the first year of life, then decreasing 
gradually towards adulthood. Interestingly, only 
Elmlinger et al. found moderate increase in TT4 
around 7 years of age (26). Some authors reported 
significantly higher TT4 concentrations in females 
during adolescence (12,20). We did not find sex re-
lated differences, which is comparable only with 
Elmlinger et al. (26). Due to relatively small sample 
number in our study, the lack of gender effect on 
TT4 concentration should be explored on a larger 
sample size. As for TT3 in the eldest group, our 
data did not show sex related differences, which is 
consistent with two other studies (25,26). Even 
though the CALIPER study reported modest differ-
ence between sexes, our TT3 RIs are in best agree-
ment with their results (12). 
Throughout all age groups, our data showed 
slightly different FT3 concentration in lower refer-
ence limit, possibly due to population differences. 
The concentration of FT3 showed moderate 
changes after the first year until 11 to 14 years of 
age, where most other studies observed signifi-
cantly higher concentrations in males (10,12,27). 
Sex differences in adolescents can be attributed to 
the effects of the oestrogens, growth hormone 
and insulin-like growth factor 1 on enhanced pe-
ripheral conversion (28,29). In contrast to other re-
ports, our results showed that there were no sex 
related differences in adolescents with SDRSex < 
0.3. However, visually plotted data showed shift to 
lower concentrations in adolescent females. This 
discrepancy could be the result of relatively small 
sample size, so we decided to separate adolescent 
FT3 RIs by sex. The FT3 concentration in adoles-
cent are slightly lower both in lower and upper 
limit compared to some authors, but similar to the 
CALIPER eldest group (10,12,13,27,30). 
FT4 concentration followed TSH surge in new-
borns. Despite the fact that the same upper age 
limit at 15 days was used, our study showed signif-
icantly lower FT4 results than the CALIPER study 
(12). In contrast, Soldin et al. results were similar to 
ours, but with upper age limit set to 2 months (14). 
After the first year of life, FT4 remained stable until 
adulthood. Estimated RIs were similar to others 
within the Abbott group (10,11,13,14). Exception 
was the CALIPER study which used the same age 
group as ours (1 year to < 19 years) but found high-
er upper reference limit (12,27). 
In general, previous studies reported significant 
changes in thyroid function tests after birth until 
adulthood. The current study results showed simi-
lar pattern with all thyroid function test concentra-














Male Female Male Female Male Female Male Female







Male Female Male Female Male Female









https://doi.org/10.11613/BM.2021.030702 Biochem Med (Zagreb) 2021;31(3):030702 
  7
Bokulić A. et al. Paediatric reference intervals for thyroid function tests
falling to adult concentrations. Regardless of dif-
ferences in age partitioning between studies, our 
results are in close agreement with RIs for TSH in 
method-matched studies. In contrast, our RIs for 
other thyroid hormones showed significant shift in 
upper or lower limits. CALIPER Paediatric Refer-
ence Interval Database is one of most important 
databases for RIs in children and adolescents as it 
is based on a large sample of healthy population. 
This certainly eases the implementation of CALI-
PER based RIs in many laboratories. However, pop-
ulation differences do exist and require re-estima-
tion of the same, as confirmed by this study re-
sults.
Reference intervals derived from this study are 
limited by the fact that samples were collected 
from hospital in- and out- paediatric patients rath-
er than from healthy community children. In addi-
tion, samples were collected at only one hospital 
centre in the biggest central region of Croatia. Al-
though Croatian population is homogenous, re-
gional differences still may be present. Underlying 
diseases could influence the results despite our 
best efforts to exclude children with conditions 
potentially affecting thyroid hormones’ metabo-
lism. Although the recommended number of 120 
samples per group was not always achieved, ap-
propriate statistical methods according to CLSI 
guidelines were used (1). We did not take into ac-
count body mass index and puberty stage which 
could influence RIs as suggested by some authors 
(16,30). Iodine status was not measured since Cro-
atia is a country with sufficient iodine intake (31).
To our knowledge, this is the first study conducted 
on paediatric patients for thyroid function tests in 
Croatia. Partitioning RIs by age and sex was con-
firmed with calculated SDR from two-level nested 
ANOVA. We propose RIs for widely used Abbott 
platform, thus giving Croatian laboratories meth-
od- and population- specific paediatric RIs for thy-
roid function tests that should improve clinical test 
interpretation. Before implementing, laboratories 
still need to verify our proposed RIs based on CLSI 
protocol defined by C28-A3 guidelines (1).
Potential conflict of interest
None declared.
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